Regulatory Divergence Between United States and European Direct‐to‐Consumer Skin Cancer Platforms Shapes Patient Safety and Follow‐Up Pathways
International Journal of Dermatology · 2026-08 · 65 (8) · 1694-1697
DOI: 10.1111/ijd.70453 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Dermatology, online erschienen am 29.04.2026. Verfasst von Isabella Sharifi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miami, Florida, USA. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miami, Florida, USA.
ORCID-Profile: Isabella Sharifi
Zitieren
APA
Sharifi, I., Kraft, G., & Nouri, K. (2026). Regulatory Divergence Between United States and European Direct‐to‐Consumer Skin Cancer Platforms Shapes Patient Safety and Follow‐Up Pathways. International Journal of Dermatology, 65(8), 1694-1697. https://doi.org/10.1111/ijd.70453
Vancouver
Sharifi I, Kraft G, Nouri K. Regulatory Divergence Between United States and European Direct‐to‐Consumer Skin Cancer Platforms Shapes Patient Safety and Follow‐Up Pathways. International Journal of Dermatology. 2026;65(8):1694-1697. doi:10.1111/ijd.70453
BibTeX
@article{Sharifi2026,
author = {Sharifi, Isabella and Kraft, Garrett and Nouri, Keyvan},
title = {Regulatory Divergence Between United States and European Direct‐to‐Consumer Skin Cancer Platforms Shapes Patient Safety and Follow‐Up Pathways},
journal = {International Journal of Dermatology},
year = {2026},
volume = {65},
number = {8},
pages = {1694--1697},
doi = {10.1111/ijd.70453}
}
EUVIMED